copper intrauterine devices
Summary: Intrauterine contraceptive devices that depend on the release of metallic copper.
Publications130 found, 100 shown here
- [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]F Imperato
II Facolta di Medicina e Chirurgia, Istituto di Ostetricia e Ginecologia, Universita degli Studi La Sapienza, Rome, Italy
Minerva Ginecol 54:271-8. 2002..The authors evaluated the effect of copper surface area on uterine bleeding...
- IUDs: which device?Jo Dennis
Abacus Centres for Family Planning and Reproductive Health, Liverpool, UK
J Fam Plann Reprod Health Care 28:61-8. 2002
- Mechanisms of action of intrauterine devices: update and estimation of postfertilization effectsJoseph B Stanford
Department of Family and Preventive Medicine, University of Utah Health Research Center, Salt Lake City 84108, USA
Am J Obstet Gynecol 187:1699-708. 2002....
- Assessment of menstrual blood loss in Brazilian users of the frameless copper-releasing IUD with copper surface area of 330 mm2 and the frameless levonorgestrel-releasing intrauterine systemA T L Andrade
Maternidade Therezinha de Jesus, Centro de Biologia da Reprodução, Universidade Federal, Juiz de Fora, Brazil
Contraception 70:173-7. 2004..Heavy and abnormal MBL is the main reason for discontinuation of intrauterine devices...
- Use of copper intrauterine devices and the risk of tubal infertility among nulligravid womenD Hubacher
Family Health International, Research Triangle Park, NC 27709, USA
N Engl J Med 345:561-7. 2001..The concern that IUDs that contain copper--currently the most commonly used type--may increase the risk of infertility in nulligravid women has limited the use of this highly effective method of birth control...
- TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of ageLuis Bahamondes
Human Reproduction Unit, Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas UNICAMP, Campinas 13084 971, Brazil
Contraception 72:337-41. 2005..The objective of the study was to evaluate the performance of the TCu 380A IUD in women who had been using the device for more than 10 years and who were 35 years of age or more on completion of the 10th year of IUD use...
- Ectopic pregnancy among non-medicated and copper-containing intrauterine device users: a 10-year follow-upSanjay Ganacharya
Department of Obstetrics and Gynecology, Medical and Health Science Center, University of Debrecen, P O Box 37, Nagyerdei krt 98, H 4012 Debrecen, Hungary
Eur J Obstet Gynecol Reprod Biol 111:78-82. 2003..To compare ectopic pregnancy (EP) rates among users of non-medicated and copper-containing IUDs...
- Cochrane systematic reviews of IUD trials: lessons learnedDavid A Grimes
Family Health, International, P O Box 13950, Research Triangle Park, NC 27796, USA
Contraception 75:S55-9. 2007..Intrauterine devices (IUDs) are the most widely used reversible contraceptives in the world today, and decisions about their use should reflect the best available evidence...
- New frameless and framed intrauterine devices and systems - an overviewDirk Wildemeersch
Contrel Research, Technology Park, University of Ghent, 9000 Ghent, Belgium
Contraception 75:S82-92. 2007..In some women, the use of misoprostol 400 microg, 3 h prior to fitting of the IUD/IUS, may be useful to dilate the cervical canal. The popularity of the IUD could be much improved if attention is given to this aspect of IUD insertion...
- Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, BelgiumJ Pincemail
Department of Cardiovascular Surgery, University of Liege, CHU Sart Tilman, 4000 Liege, Belgium
Hum Reprod 22:2335-43. 2007..Among conditions known to influence oxidative stress, the use of oral contraception (OC) in women has been a matter of ongoing discussion...
- Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-upPaivi Pakarinen
Steroid Research Laboratory, Biochemistry, Institute of Biomedicine, Biomedicum, University of Helsinki, Helsinki, Finland
Contraception 68:31-4. 2003..Mirena was more effective and the rate of adverse events was lower than with NovaT. Special attention should be paid to the insertion procedure when carried out at the time of abortion...
- The 'frameless' intrauterine system for long-term, reversible contraception: a review of 15 years of clinical experienceDirk Wildemeersch
Contrel Research, Technology Park, University of Ghent, Belgium
J Obstet Gynaecol Res 29:164-73. 2003..The development of the 'frameless' intrauterine system (IUS) is a response to the growing need to develop high-performing, long-acting, reversible, and acceptable contraceptives with a high continuation of use...
- [Inconveniences and complications after insertion of IUDs by general practitioners]Jytte Rothmann Johansen
København Universitet, Institut for Folkesundhedsvidenskab, Afdeling for Almen Medicin, København
Ugeskr Laeger 166:3190-4. 2004
- IUD In Situ?Colleen Dy
J Obstet Gynaecol Can 30:107-8. 2008
- [Non hormonal contraception]Geoffroy Robin
Service de gynécologie médicale et médecine du couple, Hopital Jeanne de Flandre, CHRU de Lille, 59037 Lille
Rev Prat 58:29-40. 2008Excluded hormonal contraceptives, there are non hormonal means of contraception. Among them, copper intrauterine devices (IUD) are very efficient...
- Removal of copper-bearing IUDs in asymptomatic patients. ReplyJyoti Jatti
J Fam Plann Reprod Health Care 34:136. 2008
- Options for intrauterine contraceptionHeidi Collins Fantasia
William F Connell School of Nursing, Boston College, Chestnut Hill, MA, USA
J Obstet Gynecol Neonatal Nurs 37:375-83. 2008..A greater understanding of the benefits and limitations of these two contraceptive options will assist women's health care providers to better meet the family planning needs of their patients...
- Sonographic and Doppler flow characteristics of levonorgestrel and copper-releasing intrauterine devicesYaron Zalel
Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
MedGenMed 5:38. 2003
- A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDsTommy Haugan
Department of Epidemiology, SINTEF Health Research, N 7465 Trondheim, Norway
Contraception 75:171-6. 2007The objective of this open randomized study was to compare the clinical performance of Nova T380 and Gyne T380 Slimline copper intrauterine devices (IUDs).
- [Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil]Daniela Angerame Yela
Departamento de Obstetricia e Ginecologia, Faculdade de Medicina, Universidade Estadual de Campinas UNICAMP, Campinas, Brazil
Rev Assoc Med Bras 52:32-6. 2006....
- Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trialSvetlana Rogovskaya
Research Center of Obstetrics, Gynecology, and Perinatology, Russian Academy of Medical Science, Moscow, Russia
Obstet Gynecol 105:811-5. 2005..To examine the effect of the levonorgestrel-releasing intrauterine system on glucose metabolism in diabetic women...
- Transuterine migration as a complication of intrauterine contraceptive devices: six case reportsY A Tuncay
SSK Goztepe Educational Hospital, Clinic of Obstetrics and Gynecology, Istanbul, Turkey
Eur J Contracept Reprod Health Care 9:194-200. 2004..Although an IUD is an effective contraceptive method, the migration of one is a rare but serious complication. The aim of this report is to emphasize the management and therapy of this complication...
- [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium]Zhi Min Xin
Reproductive Medical Center, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
Zhonghua Fu Chan Ke Za Zhi 39:771-5. 2004....
- Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire surveyA Ben-Haroush
Department of Obstetrics and Gynecology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Eur J Contracept Reprod Health Care 9:29-33. 2004..In addition, physician knowledge of patient satisfaction with the device was evaluated...
- Contraception for the older woman: an updateR K Bhathena
Department of Obstetrics and Gynaecology, Petit Parsee General and Masina Hospitals, Bombay, India
Climacteric 9:264-76. 2006..The woman should be provided with individualized advice so that she has a choice between the newer, effective, largely safe, reversible methods and sterilization...
- The intrauterine device: rethinking old paradigmsKatherine W Morgan
University of Utah College of Nursing, 10 South 2000 East, Salt Lake City, UT 84112, USA
J Midwifery Womens Health 51:464-70. 2006..In light of this data, the IUD should be made available to women at low-risk for sexually-transmitted infections and should not be denied to women on the basis of parity or marital status...
- Intrauterine contraception: the role of general practitioners in four Dutch general practicesAnnika A G Vos
Women s Studies in Medicine, Department of General Practice, University of Nijmegen, Nijmegen, The Netherlands
Contraception 69:283-7. 2004..General practitioners clearly follow their own opinions about inserting IUD in nulliparous women. Currently, general practitioners are prescribing more Multiload Cu 375 IUDs and levonorgestrel-releasing IUDs...
- Clinical outcomes of early postplacental insertion of intrauterine contraceptive devicesSevki Celen
Zekai Tahir Burak Women Health Education and Research Hospital, Ankara, Turkey
Contraception 69:279-82. 2004..To assess the efficacy, safety and, thus, advantages and disadvantages, of early postplacental intrauterine device (IUD) insertion...
- Surgical management of intra-abdominal mislocated intrauterine devicesMahmut T Ozgun
Department of Obstetrics and Gynecology, Faculty of Medicine, Gevher Nesibe Hospital, Erciyes University, 38039 Kayseri, Turkey
Contraception 75:96-100. 2007..We report on our experience in surgical treatment of patients with intra-abdominal intrauterine devices (IUDs)...
- Problems in the conduct and analysis of "A comparative randomized study of three different IUDs in nulliparous Mexican women"Irving Sivin
Contraception 69:259-60. 2004
- Intrauterine contraception: an updateR K Bhathena
Department of Obstetrics and Gynaecology, B D Petit Parsee General and Masina Hospitals, Bombay, India
J Obstet Gynaecol 28:262-5. 2008
- Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New ZealandMira Harrison-Woolrych
Intensive Medicines Monitoring Programme, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
N Z Med J 116:U538. 2003..To compare the incidence of reported insertion problems with the levonorgestrel-releasing intrauterine device (Mirena) with that of the copper device Multiload Cu 375...
- Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot studyD Wildemeersch
Contrel Research, Technology Park Zwijnaarde, Ghent, Belgium
Contraception 66:93-9. 2002....
- Efficacy of a mini version of the frameless GyneFix intrauterine system (IUS) with effective copper surface area of 200 mm2. firstname.lastname@example.orgDirk Wildemeersch
Contrel Research, Ghent, Belgium
Contraception 66:237-41. 2002..This is made possible by anchoring the active contraceptive substance to the fundus of the uterus. The fact that 100% of the copper surface area of the frameless IUS is available for copper release is an additional advantage...
- Insertion of an intrauterine contraceptive device after induced or spontaneous abortion: a review of the evidenceN L Stanwood
Robert Wood Johnson Clinical Scholars Program, University of North Carolina School of Medicine, Chapel Hill, USA
BJOG 108:1168-73. 2001..Immediate insertion may have a higher expulsion rate than delayed insertion. However, these risks may be outweighed by the benefit of immediate contraception...
- Outcomes at 1 year for the first 200 patients fitted with GyneFix at Margaret Pyke CentreT Masters
Avon Brook, Bristol, UK
Eur J Contracept Reprod Health Care 7:65-70. 2002..However, they are perhaps not as good as had been anticipated for this revolutionary new intrauterine implant. Possible reasons for this are explored...
- [Intrauterine devices in general practice: a prospective study of 300 insertions]H Marret
Département de gynécologie obstétrique, Medecine Foetale et Reproduction Humaine, Hopital Bretonneau, 2, boulevard Tonnelle, 37044 Tours Cedex 1, France
J Gynecol Obstet Biol Reprod (Paris) 31:465-70. 2002To assess the effectiveness of management practices of copper intrauterine devices (IUD) in general medicine.
- [Use of 3-dimensional ultrasound for assessment of intrauterine device position]I Hösli
Geburtshilfe und Schwangerschaftsmedizin, Universitats Frauenklinik Basel
Ultraschall Med 22:75-80. 2001..The purpose of our prospective study was to assess the accuracy of measuring and visualizing different types of IUDs with three dimensional ultrasound (3D) and two dimensional ultrasound (2D)...
- The local progestational effect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow studyY Zalel
Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel
Hum Reprod 17:2878-80. 2002..We aimed to evaluate the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on the uterine vasculature and the endometrium...
- Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hoursCharlotte Ellertson
Ibis Reproductive Health, Cambridge, Massachusetts 02138, USA
Obstet Gynecol 101:1168-71. 2003..The purpose of this study was to determine whether the window for emergency hormonal contraception can be extended to 120 hours...
- State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devicesIrving Sivin
Population Council, New York, NY10065, USA
Eur J Contracept Reprod Health Care 15:96-112. 2010..Yet other research lines indicate noncontraceptive benefits of copper intrauterine devices in protecting against endometrial cancer, and favourable risk-benefit analyses of IUD use by women at ..
- Efficacy of contraceptive methods: A review of the literatureDiana Mansour
New Croft Centre, Newcastle upon Tyne, UK
Eur J Contracept Reprod Health Care 15:4-16. 2010..To provide a comprehensive and objective summary of contraceptive failure rates for a variety of methods based on a systematic review of the literature...
- Copper hypersensitivity: dermatologic aspects--an overviewJurij J Hostynek
Euromerican Technology Resources, Inc, Lafayette, California 94549, USA
Rev Environ Health 18:153-83. 2003..systemic allergic reactions (SAR) and contact stomatitis (STO), but considering the widespread use of copper intrauterine devices (IUDs) and the importance of copper in coinage, items of personal adornment and industry, unambiguous ..
- [Reasons for removal of intrauterine devices among women in general practice]Line Kolding
Kvindeafdelingen, Regionshospitalet Viborg, Heibergs Alle 4, 8800 Viborg, Denmark
Ugeskr Laeger 175:884-6. 2013..In general the women were satisfied with both types of IUDs. More women with copper-releasing IUDs had an early removal because of complaints than women with levonorgestrel-releasing IUDs...
- Insertion and removal of intrauterine devicesBrett Andrew Johnson
Methodist Charlton Medical Center, Dallas, Texas 75237, USA
Am Fam Physician 71:95-102. 2005..The IUD is inserted into the uterus according to individual protocols, with the threads cut at a length to allow the patient to check the device's position. Expulsion may occur with both types of IUDs...
- Copper intrauterine device use by nulliparous women: review of side effectsDavid Hubacher
Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA
Contraception 75:S8-11. 2007..Nulliparity was once a relative contraindication to using the copper IUD. However, new research and changes in product labeling have eased safety concerns. Side effects remain a major problem with copper IUD use in this population...
- [Random comparative study between intrauterine device Multiload Cu375 and TCu 380a inserted in the postpartum period]Roger Lara Ricalde
Departamento de planificación familiar del Instituto Naciónal de Perinatología Lomas Virreyes, Mexico
Ginecol Obstet Mex 74:306-11. 2006..To evaluate safety and effectiveness of the intrauterine device Multiload Cu375 compared with the TCu 380A inserted in the postpartum period...
- Can intrauterine contraceptive devices be a Candida albicans reservoir?Francieli Chassot
Division of Clinical Cytology, Teaching and Research in Clinical Analysis Laboratory, State University of Maringa, Maringa, Parana, Brazil
Contraception 77:355-9. 2008..The in vitro adherence of Candida albicans isolated from vaginal exudates of patients with vulvovaginal candidiasis (VVC) to intrauterine contraceptive devices (IUDs) and biofilm formation capacity were evaluated...
- Contraception and HIV infection in womenOskari Heikinheimo
Department of Obstetrics and Gynaecology, University of Helsinki, Finland
Hum Reprod Update 15:165-76. 2009..This review aims to show the effect of contraceptive choices on risk of HIV and on the course of disease in women with HIV...
- Persistent subumbilical discharge associated with actinomycosis caused by intrauterine contraceptive device: a case reportIbrahim Polat
Gynecological Clinic, Istanbul Bakirkoy Woman and Children Hospital, Istanbul, Turkey
Arch Gynecol Obstet 277:457-60. 2008..We recommend consideration of this minor possibility during evaluation of women with chronic abdominal discharge...
- Pyosalpinx caused by the tubal migration of an intrauterine device--a case reportSuna Ozdemir
Department of Gynaecology and Obstetrics, Meram Medical Faculty, Selcuk University, Konya, Turkey
Eur J Contracept Reprod Health Care 13:320-2. 2008..Tubal migration of an IUD is extremely rare and little is known about its mechanism. We describe a case of pyosalpinx caused by the tubal migration of a copper IUD. The tail of the device was embedded in the mesocolon...
- Health care providers' knowledge of, attitudes toward and provision of emergency contraceptives in Lagos, NigeriaOlufunke Margaret Ebuehi
Institute of Child Health and Primary Care, Department of Biochemistry, College of Medicine, University of Lagos, Lagos, Nigeria
Int Fam Plan Perspect 32:89-93. 2006..Emergency contraception can play an important role in reducing the rate of unintended pregnancies in Nigeria. Although it is included in the national family planning guidelines, there is limited awareness of this method among clients...
- Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraceptionP D Blumenthal
Department of Obstetrics and Gynecology, Stanford University, Stanford, CA 94305 5317, USA
Hum Reprod Update 17:121-37. 2011..In this review we aim to discuss the role of LARC methods and importance of contraceptive counseling in reducing unintended pregnancy rates...
- Release behavior of cupric ions for TCu380A and TCu220C IUDsBianmei Cao
School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, People s Republic of China
Biomed Mater 3:044114. 2008..The main compounds identified were cuprite (Cu(2)O). Copper wire and copper tubes were implanted in the uteruses of rats. In vivo experiments were also done. The corrosion rate in vivo was higher than that in vitro...
- Intrauterine device use among women with uterine fibroids: a systematic reviewLauren B Zapata
Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
Contraception 82:41-55. 2010....
- Intrauterine contraceptives that do not fit well contribute to early discontinuationDirk Wildemeersch
Contrel Research, Technology Park, University of Ghent, Ghent, Belgium
Eur J Contracept Reprod Health Care 16:135-41. 2011To shed additional light on various aspects of intrauterine contraception discussed recently in a comprehensive review article and on the continued development of frameless copper intrauterine devices (IUDs).
- [Effects of herb therapy for benefiting qi and removing blood stasis on ultrastructure of vascular endothelial cells and vascular smooth muscle cells of uterine endometrium in rabbits with copper intrauterine device]Lei Lei
Department of Integrated Traditional Chinese and Western Medicine, Hunan College of Traditional Chinese Medicine, Changsha, Hunan Province 410007, China
Zhong Xi Yi Jie He Xue Bao 4:60-3. 2006....
- A comparative study of the levonorgestrel-releasing intrauterine system Mirena versus the Copper T380A intrauterine device during lactation: breast-feeding performance, infant growth and infant developmentAyman H Shaamash
Department of Obstetrics and Gynecology, Faculty of Medicine, Assiut University, Assiut, Egypt
Contraception 72:346-51. 2005..Mirena is a levonorgestrel-releasing intrauterine system (LNG-IUS) that provides highly effective and long-acting progestogen-only contraception...
- The intrauterine device in modern contraception: Still an actuality?Andrea Tinelli
Department of Obstetrics and Gynecology, Vito Fazzi Hospital, Lecce, Italy
Eur J Contracept Reprod Health Care 11:197-201. 2006....
- Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofenDavid Hubacher
Family Health International, Research Triangle Park, NC, USA
Am J Obstet Gynecol 195:1272-7. 2006..This study was undertaken to determine whether 400 mg of prophylactic ibuprofen can alleviate pain from insertion of an intrauterine device (IUD) and to measure level of pain with improved techniques...
- Variations in body mass index of users of depot-medroxyprogesterone acetate as a contraceptiveMárcia Pantoja
Human Reproduction Unit, Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas UNICAMP, and National Institute of Hormones and Women Health, Campinas, SP 13084 971, Brazil
Contraception 81:107-11. 2010..Weight gain is a frequent reason for discontinuing the contraceptive with depot-medroxyprogesterone acetate (DMPA)...
- Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of actionMaría Elena Ortiz
Instituto Chileno de Medicina Reproductiva, Postal code 6500970, Santiago, Chile
Contraception 75:S16-30. 2007..The common belief that the usual mechanism of action of IUDs in women is destruction of embryos in the uterus is not supported by empirical evidence...
- Transverse limb reduction and intrauterine device: case report and review of the literatureAlina Weissmann-Brenner
Helen Schneider Hospital for Women, Rabin Medical Center, Campus Beilinson, Petah Tiqva, Israel
Eur J Contracept Reprod Health Care 12:294-7. 2007..Pregnancies with an intrauterine device (IUD) in situ are associated with increased maternal and foetal morbidity and mortality. No proven teratogenetic effects have been attributed to IUDs...
- ContraceptionG R Huggins
Francis Scott Key Medical Center, Baltimore, Maryland
Curr Opin Obstet Gynecol 2:291-5. 1990..However, the risk was overstated earlier. Women who have only 1 sexual partner in their lifetime had no significant risk of tubal infertility. "lost" IUDs continue to be a problem...
- Reaching providers is not enough to increase IUD use: a factorial experiment of 'academic detailing' in KenyaJennifer Wesson
Family Health International, North Carolina, USA
J Biosoc Sci 40:69-82. 2008..However, the cost of the detailing in comparison to the small number of IUDs inserted indicates that this intervention is not cost-effective...
- Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative studyYing Woo Ng
Department of Obstetrics and Gynaecology, National University Hospital, Singapore 119074, Singapore
Contraception 79:24-8. 2009..This study aims to assess the effects of levonorgestrel-releasing intrauterine system (LNG-IUS) on lipid metabolism in an Asian population using Ortho Gynae T380 copper containing (nonhormonal) intrauterine device (IUD) as a control...
- The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guidelineI Mavranezouli
National Collaborating Centre for Women s and Children s Health NCC WCH, Royal College of Obstetricians and Gynaecologists, London, UK
Hum Reprod 23:1338-45. 2008..However, their uptake is low in much of the developed world. This study aimed at assessing the cost-effectiveness of LARC methods from the British National Health Service (NHS) perspective...
- The acceptance rate of intrauterine contraceptive device (IUCD) amongst family planning clinic users in Lagos University Teaching Hospital (LUTH)O Adegbola
Department of Obstetrics and Gynaecology, College of Medicine, University of Lagos, Lagos University Teaching Hospital, Lagos
Nig Q J Hosp Med 18:175-80. 2008..Intrauterine Contraceptive Device is an effective reversible long-term contraceptive method that is popular and widely used in this environment...
- Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?R Neale
Department of Genitourinary Medicine, Royal Cornwall Hospital NHS Trust, Truro, Cornwall TR1 3LJ, UK
Int J STD AIDS 20:423-4. 2009..More women with an IUCD developed BV compared with an IUS at 4-6 weeks and six months. However, there were insufficient numbers of women with BV to demonstrate any significant difference between the vaginal flora of the two groups...
- Intrauterine device insertion during the postpartum period: a systematic reviewNathalie Kapp
Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
Contraception 80:327-36. 2009..Insertion of an intrauterine device (IUD) at different times or by different routes during the postpartum period may increase the risk of complications...
- Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic diseaseMary E Gaffield
Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
Contraception 80:363-71. 2009..Women diagnosed with gestational trophoblastic disease (GTD) need safe and effective contraception because they are advised to delay a subsequent pregnancy...
- Effects of a copper-medicated intrauterine device on ovarian artery, uterine artery, and intrauterine blood flowO Shen
Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel
Gynecol Obstet Invest 66:253-6. 2008..To determine the effect of a copper-medicated intrauterine device (IUD) on ovarian, uterine, arcuate, radial and subendometrial Doppler-derived indices of blood flow...
- Copper T 380A IUD and magnetic resonance imagingMiriam Zieman
Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
Contraception 75:93-5. 2007..Prior testing of the Copper T 380A intrauterine device (IUD) has been done using MR systems of 1.5 T or less. This study was performed to test this IUD in a MR system of 3.0 T...
- Intrauterine contraception: it's not what you thinkDeana Vaughn
Women s Health Section, TN Department of Health, Nashville, USA
Tenn Med 99:38, 40. 2006..Our daughters are discovering intrauterine contraception. As their healthcare providers, we are in a position to educate them as they come to the office with questions. We should be prepared to give them current and accurate information...
- Estrogen-progestogen once-a-month injectable contraceptives and serum prolactinJ Garza-Flores
Departamento de Biologia, Instituto Nacional de la Nutrición S Zubirán, Mexico City, Mexico
Contraception 39:519-29. 1989..Overall, the data demonstrated that the chronic administration of these estrogen/progestogen once-a-month injectable contraceptives does not affect the Prl baseline secretion in women...
- Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported?Mira Harrison-Woolrych
Intensive Medicines Monitoring Programme, University of Otago, Dunedin, New Zealand
Contraception 67:53-6. 2003....
- Study on the effects of FCu-IUD and FICu-IUD on matrix metalloproteinases in human uterine flushing and endometriumWei Li
Family Planning Research Institute, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030
J Huazhong Univ Sci Technolog Med Sci 22:9-11, 16. 2002....
- Comparative trial of the force required for, and pain of, removing GyneFix versus Gyne-T380S following randomised insertionRachel E D'Souza
Margaret Pyke Centre, London, UK
J Fam Plann Reprod Health Care 29:29-31. 2003..To assess the force required for, and pain of, removal of the GyneFix as compared with T-framed intrauterine devices (IUDs)...
- A comparative randomized study of three different IUDs in nulliparous Mexican womenJ B Otero-Flores
Reproductive Health Coordination, Division of Family Planning Mexican Institute of Social Security IMSS, Mier y Pesado 120, Colonia del Valle, Mexico 03100, DF, Mexico City, Mexico
Contraception 67:273-6. 2003..5% (+/-0.3) in TCu 380 Nul, and no pregnancy in ML Cu 375 sl (p < 0.05). Especially designed IUDs for nulliparous women had a better clinical profile compared with the standard IUD. This may improve the use of IUD in this population...
- Characterization of copper in uterine fluids of patients who use the copper T-380A intrauterine deviceVeronica Arancibia
Facultad de Quimica, Pontificia Universidad Catolica de Chile, Chile
Clin Chim Acta 332:69-78. 2003..However, there is little information about the amount and form of copper in the fluid and whether the presence of this element produces any change in the protein concentration...
- Laparoscopic removal of an intraperitoneal translocated intrauterine contraceptive deviceL Miranda
Department of General Surgery, Center of Laparoscopic Surgery, Monaldi Hospital, Naples, Italy
Eur J Contracept Reprod Health Care 8:122-5. 2003..From that time on, she started to complain of the above-mentioned symptoms. She had an abdominal X-ray which revealed the IUD in the abdominal cavity. She then underwent a laparoscopic removal of the translocated IUD...
- Unrecognised perforation of the uterus into bladder by an IUDA Honarbakhsh
Department of Radiology and Ultrasonography, Madaen Hospital, Tehran, Iran
J Obstet Gynaecol 23:444-5. 2003
- Perforation with the GyneFix intrauterine implant: is there a common factor?Thomas R Aust
Department of Gynaecology, Liverpool Women s Hospital, Liverpool, UK
J Fam Plann Reprod Health Care 29:155-6. 2003..A review of all other reports of this complication has been performed. Analysis of these reports suggests prolonged amenorrhoea secondary to continuous progestogen use as a possible common predisposing factor...
- Ectopic pregnancy risk when contraception fails. A reviewLesley Anne Furlong
U S Food and Drug Administration, HFD 580, 5600 Fishers Lane, Rockville, MD 20857, USA
J Reprod Med 47:881-5. 2002..To alert clinicians to the risk of ectopic pregnancy when certain contraceptive methods fail by summarizing data from trials reviewed by the U.S. Food and Drug Administration (FDA)...
- Intravesical migration of intrauterine device resulting in stone formationrfan H Atakan
Department of Urology, University of Trakya Faculty of Medicine, Edirne, Turkey
Urology 60:911. 2002..We report on a 27-year-old woman in whom an intrauterine contraceptive device (Copper-T) migrated from the uterus to the bladder and resulted in formation of a stone...
- Intrauterine devicesXiao Bilian
National Research Institute for Family Planning, No 12 Da Hui Si, Beijing 100081, People s Republic of China
Best Pract Res Clin Obstet Gynaecol 16:155-68. 2002..The copper IUD is the most effective method for emergency contraception. It can prevent over 95% of unwanted pregnancies within 5 days of unprotected intercourse...
- Late uterine perforation with an anchored IUD, the Gynefix: a case reportM Vekemans
Universite Libre de Bruxelles, Brussels, Belgium
Contraception 60:55-6. 1999..The incidence of this complication is unknown. The appropriateness or need of assessing echo-graphically the myometrial thickness before the insertion and of controlling its correct position after the insertion remains uncertain...
- Magnetic resonance imaging appearances of the Mirena and GyneFix intra-uterine contraceptive devices: a report of two casesG H Hall
Centre for Magnetic Resonance Investigations, University of Hull at Hull Royal Infirmary, Hull, UK
Br J Fam Plann 26:224-6. 2000....
- Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating womenS Ratchanon
Reproductive Medicine and Family Planning Units, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
Obstet Gynecol 96:926-8. 2000..To study the effect of depot medroxyprogesterone acetate on basal serum prolactin levels in lactating women...
- Evaluation of postabortion IUD insertion in Egyptian womenA Moussa
Department of Obstetrics and Gynecology, Alazhar School of Medicine, Cairo, Egypt
Contraception 63:315-7. 2001..This study showed that insertion of an IUD immediately after a spontaneous abortion is safe and could be offered to those who have had an abortion and who ask for a method of contraception...
- Copper intrauterine devices and tubal infertility among nulligravid womenVeronique Verhoeven
N Engl J Med 346:376-7. 2002
- Noncontraceptive health benefits of intrauterine devices: a systematic reviewDavid Hubacher
Family Health International, Research Triangle Park, North Carolina 27709, USA
Obstet Gynecol Surv 57:120-8. 2002..Like oral contraceptives, intrauterine contraceptives confer important noncontraceptive health benefits...
- Contraceptive efficacy and clinical performance of Nestorone implants in postpartum womenM R Massai
Instituto Chileno de Medicina Reproductiva, Consultorio de Planificacion Familiar, J V Lastarria 29, Depto 101, Santiago, Chile
Contraception 64:369-76. 2001..2%). Concentrations of NES in breast milk ranged between 54-135 pmol/liter. The Nestorone implant is a highly effective contraceptive, safe for breastfed infants because the steroid is inactive by the oral route...
- The effect on intrauterine device position and performance of a modified TCu380A insertion techniqueK Homouda
Department of Obstetrics and Gynecology, Ain Shams University School of Medicine, Cairo, Egypt
Eur J Contracept Reprod Health Care 7:31-5. 2002..To assess the validity of modifying the technique of intrauterine device (IUD) placement to decrease the incidence of incorrect positioning within the uterine cavity...
- [A multicentre comparative clinical study of uterine cavity shaped device Cu300, TCu220C and TCu380A in ten years]He Ping Chen
Affiliated Hospital, Chongqing Family Planning Scientific Research Institute, Chongqing 400020, China
Zhonghua Fu Chan Ke Za Zhi 38:298-301. 2003..To observe the clinical effects of uterine cavity shaped device (UCD) Cu300, TCu220C and TCu380A in ten years...
- Uterine factors and risk of pregnancy in IUD users: a nested case-control studyAngels Avecilla-Palau
Centre d Atenció a la Salut Sexual i Reproductiva, Hospital Municipal de Badalona, Badalona Serveis Assistencials, C Mare de Déu de Lorda 119 125, 08915 Badalona, Spain
Contraception 67:235-9. 2003..The findings suggest that the gynecological characteristics of the woman analyzed should not be a criterion for the selection of potential IUD users...
- Assessment of menstrual blood loss in Belgian users of the frameless copper-releasing IUD with copper surface area of 200 mm2 and users of a copper-levonorgestrel-releasing intrauterine systemD Wildemeersch
Contrel Research, Ghent, Belgium
Contraception 70:169-72. 2004..This study was conducted to evaluate the effect of a miniaturized frameless copper IUD (GyneFix 200 small) and a copper-levonorgestrel (GynePlant) intrauterine system (IUS) on the amount of menstrual blood loss (MBL)...
- The release of cupric ion in simulated uterine: New material nano-Cu/low-density polyethylene used for intrauterine devicesT Xu
Materials Center, Guizhou University of Technology, Guiyang, 550003, P R China
Contraception 70:153-7. 2004..The aim of this study was to investigate copper ion release from this composite as a basis for considering its used in an IUD...
- Pre-malignant and malignant cervical pathologies among inert and copper-bearing intrauterine contraceptive device users: a 10-year follow-up studySanjay Ganacharya
Department of Obstetrics and Gynaecology, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary
Eur J Contracept Reprod Health Care 11:89-97. 2006..The aim of the study was to compare the incidence of pre-malignant and malignant cervical conditions during a period of 10 years of use of inert (Szontagh) and copper-bearing IUCDs...
- Expulsion of part of a spontaneously broken IUCDP Sinha
Conquest Hospital, St Leonards on Sea, East Sussex TN37 7RD, UK
J Obstet Gynaecol 24:837-8. 2004
- Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settingsRichard Steen
Reprod Health Matters 12:136-43. 2004..Even with safe insertion, IUD promotion in areas of high STI/HIV prevalence must address women's needs for dual protection from infection and unwanted pregnancy...
- Prophylactic Ibuprofen: Effect on IUD Continuation RatesDavid Hubacher; Fiscal Year: 2003..In the US, ibuprofen may help spur renewed interest in the most cost effective and efficacious reversible contraceptive method available. ..
- Infrastructure for Population Research at PrincetonJames Trussell; Fiscal Year: 2007..The journal Future of Children will promote effective policies and programs for children by providing policymakers, service providers, and the media with information based on the best available research. ..
- Obesity, Oral Contraception and Ovarian SuppressionCarolyn Westhoff; Fiscal Year: 2007..This study will have very good power to detect clinically important differences. Results could directly and immediately affect contraceptive practice. ..
- Contraceptive Services/Primary Care to Prevent Birth DefectsEleanor Schwarz; Fiscal Year: 2007....
- Harnessing Health IT to Prevent Medication-Induced Birth DefectsEleanor Schwarz; Fiscal Year: 2007..In addition, the Health IT intervention shown to be most effective will be disseminated within the University of Pittsburgh Medical Center, which provides 3 million outpatient visits each year...
- Demography Training at PrincetonJames Trussell; Fiscal Year: 2007....
- Training in Epidemiology and Clinical Trials (TECT)David Grimes; Fiscal Year: 2007....
- Clinical Research in Human FertilityJoseph Stanford; Fiscal Year: 2005..Standford to develop his skills and gain the expertise needed to accomplish his goals. ..
- RCT of a Novel Oral Contraceptive Initiation MethodCarolyn Westhoff; Fiscal Year: 2004..We will also assess dual method use for STD prevention in the study to adoption of and adherence to oral contraceptives. We will also assess dual method use for STD prevention in the study population. ..
- ESTIMATING EFFICACY OF A MEDICAL INTERVENTIONJames Trussell; Fiscal Year: 2001....